Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02832245 · ClinicalTrials.gov registry record

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

A clinical trial of Venous Thromboembolism, sponsored by Manuel Monreal.

Recruiting
Registry status
120,000
Enrollment target
20
Study locations

NCT02832245: Recruiting study of Venous Thromboembolism, sponsored by Manuel Monreal.

NCT02832245 is a study of Venous Thromboembolism that is actively recruiting participants, run by Manuel Monreal. The registered enrollment target is 120,000 participants, above the 3,743-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (3106% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02832245, a study of Venous Thromboembolism, is actively recruiting participants, sponsored by Manuel Monreal.

RECRUITING
Registry status
120,000 participants
Enrollment target
20
Study locations

Study Summary

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (pregnant women, elderly patients, disseminated cancer, severe renal insufficiency, patients with contraindications to anticoagulation therapy, extreme body weight, etc), with the purpose of decreasing mortality, frequency of thromboembolic recurrences as well as bleeding complications and arterial events. As an additional objective RIETE is also aimed to create predictive scores that help physicians to better identify patients with high risk of presenting some of these complications. The primary parameters recorded by the registry comprise details of each patient's clinical status, including any coexisting or underlying conditions, and the type, dose, duration and outcome (during the first 3 months of therapy) of antithrombotic treatment. Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Primary Outcome

Study endpoints are clinically recognized (and objectively confirmed) recurrences of VTE, major and minor bleeding complications, and death.

Conditions Studied

Venous Thromboembolism

Study Locations (20)

Buenos Aires

  • Clínica San Camilo - Buenos Aires
  • Hospital Italiano de Buenos Aires - Buenos Aires
  • Clínica Privada Pueyrredón - Mar del Plata

Beijing Municipality

  • The Seven Medical Center of Chinese PLA General Hospital - Beijing
  • Peking University Cancer Hospital and Institute - Beijing

Connecticut

  • Yale University School of Medicine - New Haven

Florida

  • College of Medicine - Jacksonville University of Florida - Jacksonville

Illinois

  • Evanston NorthShore University HealthSystem - Evanston

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • Northwell Health System - Manhasset

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 120,000 participants
Start Date 2001-03
Est. Completion 2027-12
Manuel Monreal

1 total trials

What NCT02832245 shows while recruiting

NCT02832245 is an observational study that tracks outcomes without assigning an intervention. Its 120,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,743-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (3106% higher).

The record links to 1 condition, with Venous Thromboembolism appearing as the primary indexed condition, and to 0 interventions.

NCT02832245 names 20 study sites across 17 states, led by Buenos Aires, Beijing Municipality, Connecticut.

Frequently Asked Questions

What is clinical trial NCT02832245 about?

NCT02832245 is a clinical study titled "Computerized Registry of Patients With Venous Thromboembolism (RIETE)". The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet t...

What is the current status of trial NCT02832245?

This trial is currently recruiting. The enrollment target is 120,000 participants. The study started on 2001-03. Estimated completion is 2027-12.

What conditions does trial NCT02832245 study?

This clinical trial studies the following conditions: Venous Thromboembolism.

Who is sponsoring clinical trial NCT02832245?

This trial is sponsored by Manuel Monreal, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02832245 being conducted?

This trial has 20 study locations across Connecticut, Florida, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Venous Thromboembolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02832245's enrollment target sits among peer trials

120,000 1st of 47 higher than 47 of 47 other Venous Thromboembolism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Venous Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03897374 · 120,000 participants

    Strategic Targeting for Optimal Prevention of Cancer

  • NCT06608758 · 120,000 participants

    End Diagnostic Overshadowing:Addressing Ableism in Diagnoses

  • NCT06251323 · 119,680 participants · NA

    Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

  • NCT02693509 · 128,026 participants

    Get With The Guidelines-Heart Failure Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT02832245

Source: ClinicalTrials.gov NCT02832245, the US trial registry maintained by the National Library of Medicine. NCT02832245 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.